Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
26
FLWS Quote, Financials, Valuation and Earnings
Last price:
$5.13
Seasonality move
:
-6.86%
Day range:
$4.99 - $5.19
52-week range:
$3.86 - $11.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.19x
P/B ratio:
1.02x
Volume:
530.7K
Avg. volume:
792.5K
1-year change:
-45.53%
Market cap:
$325.4M
Revenue:
$1.8B
EPS (TTM):
-$2.65
Analysts' Opinion
-
Consensus Rating1-800-Flowers.com has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.00, 1-800-Flowers.com has an estimated upside of 75.78% from its current price of $5.12.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $5.12.
Fair Value
-
According to the consensus of 1 analyst, 1-800-Flowers.com has 75.78% upside to fair value with a price target of $9.00 per share.
FLWS vs. S&P 500
-
Over the past 5 trading days, 1-800-Flowers.com has underperformed the S&P 500 by -0.76% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
1-800-Flowers.com does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
1-800-Flowers.com revenues have been falling on a year-over-year basis for 13 quarters in a row. In the most recent quarter 1-800-Flowers.com reported revenues of $331.5M.
Earnings Growth
-
1-800-Flowers.com has grown year-over-year earnings for 1 quarter straight. In the most recent quarter 1-800-Flowers.com reported earnings per share of -$2.80.
Enterprise value:
398M
EV / Invested capital:
0.84x
Price / LTM sales:
0.19x
EV / EBIT:
115.10x
EV / Revenue:
0.23x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-8.14x
Price / Operating cash flow:
29.15x
Enterprise value / EBITDA:
4.44x
Gross Profit (TTM):
$671.3M
Return On Assets:
-16.72%
Net Income Margin (TTM):
-9.88%
Return On Equity:
-38.44%
Return On Invested Capital:
-27.08%
Operating Margin:
-16.66%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.1B | $1.9B | $1.7B | $379.4M | $331.5M | |
| Gross Profit | $773.3M | $744.2M | $671.3M | $138.7M | $105M | |
| Operating Income | $26.7M | $21.4M | -$38.9M | -$27.9M | -$55.2M | |
| EBITDA | $8.3M | $63.1M | -$121.6M | -$11.1M | -$182.1M | |
| Diluted EPS | -$0.69 | -$0.12 | -$2.65 | -$0.26 | -$2.80 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $448.5M | $381.9M | $319.5M | $396.6M | $303.8M | |
| Total Assets | $1.1B | $1.1B | $998.8M | $1B | $806.2M | |
| Current Liabilities | $303.9M | $267.6M | $205.1M | $210.3M | $195.7M | |
| Total Liabilities | $607.2M | $594.9M | $506.8M | $554.7M | $488.5M | |
| Total Equity | $500.1M | $533.8M | $492M | $485.3M | $317.7M | |
| Total Debt | $183.7M | $167.2M | $148.1M | $189.4M | $157.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $39.5M | $142.3M | -$4.3M | -$112.7M | -$150.6M | |
| Cash From Investing | -$56M | -$41M | -$51.3M | -$8.7M | -$9.4M | |
| Cash From Financing | -$25M | $31M | -$43.7M | -$6.7M | -$2.5M | |
| Free Cash Flow | -$10.3M | $102.6M | -$48.9M | -$121.4M | -$160M | |
FLWS
Sector
Market Cap
$325.4M
$414.1M
Price % of 52-Week High
46.13%
71.89%
Dividend Yield
0%
0%
Shareholder Yield
4.81%
4.03%
1-Year Price Total Return
-45.53%
-10.9%
Beta (5-Year)
1.486
0.780
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.08
200-day SMA
Sell
Level
$7.07
Bollinger Bands (100)
Sell
Level
4.84 - 7.52
Chaikin Money Flow
Buy
Level
24.6M
20-day SMA
Buy
Level
$4.90
Relative Strength Index (RSI14)
Buy
Level
52.27
ADX Line
Sell
Level
14.26
Williams %R
Neutral
Level
-29.8246
50-day SMA
Sell
Level
$5.16
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
5.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9791)
Buy
CA Score
(Annual)
Level (0.0174)
Buy
Beneish M-Score
(Annual)
Level (-3.1099)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.9255)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
Stock Forecast FAQ
In the current month, FLWS has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The FLWS average analyst price target in the past 3 months is $9.00.
-
Where Will 1-800-Flowers.com Stock Be In 1 Year?
According to analysts, the consensus estimate is that 1-800-Flowers.com share price will rise to $9.00 per share over the next 12 months.
-
What Do Analysts Say About 1-800-Flowers.com?
Analysts are divided on their view about 1-800-Flowers.com share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that 1-800-Flowers.com is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is 1-800-Flowers.com's Price Target?
The price target for 1-800-Flowers.com over the next 1-year time period is forecast to be $9.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is FLWS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for 1-800-Flowers.com is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of FLWS?
You can purchase shares of 1-800-Flowers.com via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase 1-800-Flowers.com shares.
-
What Is The 1-800-Flowers.com Share Price Today?
1-800-Flowers.com was last trading at $5.13 per share. This represents the most recent stock quote for 1-800-Flowers.com. Yesterday, 1-800-Flowers.com closed at $5.12 per share.
-
How To Buy 1-800-Flowers.com Stock Online?
In order to purchase 1-800-Flowers.com stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is down 89.92% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is up 16.02% over the past day.
Sell
43
TNXP alert for Jun 17
Tonix Pharmaceuticals Holding [TNXP] is up 15.6% over the past day.
